A new companion diagnostic guidance document from the US Food and Drug Administration could make it easier for clinicians to determine the best treatment for oncology patients, the agency says.
The document, issued on 14 April, gives developers of companion diagnostics for use in oncology treatment additional advice on how to design and test their products to support broader indications...